Business Standard

Ajanta Pharma trades firm in a subdued market as board mulls share buyback

In the past six months, Ajanta Pharma has underperformed the market by gaining 8.9 per cent against 26 per cent rally in S&P BSE Healthcare index

20% tax on buyback may put firms with high promoter shareholding in a fix

SI Reporter Mumbai
Shares of Ajanta Pharma rose 4 per cent to Rs 1,646 on the BSE on Thursday in an otherwise subdued market after the company announced share buyback plan. Intra-day, the stock had rallied 6 per cent to Rs 1,683 in early morning trade. In comparison, the S&P BSE Sensex was down 0.24 per cent at 39,826 points, at 11:27 am.

Earlier, on October 23, 2020, Ajanta Pharma had informed that the board meeting of the Company scheduled to be held on November 03, 2020 to consider, the unaudited consolidated financial results for the quarter and half year ended September

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 29 2020 | 12:26 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to